mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.006 |
0.8 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.8 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.8 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.9 |